-
In vitro and In vivo Optical Imaging Using Water-Dispersible, Noncytotoxic, L...
A facile method for synthesis of monodisperse, biocompatible, silica coated CdSe/CdS/ZnS quantum rods (QRs) and their use as probes for in vitro and in vivo optical bioimaging... -
MOESM4 of Peripheral neuropathy in metachromatic leukodystrophy: current stat...
Additional file 4: Table S3. Ongoing clinical trials on metachromatic leukodystrophy (MLD). A summary of the ongoing clinical trials on treatment for metachromatic... -
Sensitive and Convenient Yeast Reporter Assay for High-Throughput Analysis by...
The yeast reporter assay has been widely used in various applications such as detection of endocrine disruptors and analysis of protein−protein interactions by the yeast... -
Additional file 8 of Atraumatic restorative treatment compared to the Hall Te...
Additional file 8. Ordered Logistic Regression analysis of the discomfort scores after treatment between the groups and the independent variables (considering only the... -
Additional file 1: of Medicaid prescription limits: policy trends and compara...
Online methods. Online results. Online Table S1. Sources of policy information organized by state. Online Table S2. Missing state policy information. Online Table S3. Proportion... -
Additional file 5 of Atraumatic restorative treatment compared to the Hall Te...
Additional file 5. Participants’ baseline characteristics. -
Additional file 1 of Measurable residual disease in multiple myeloma: ready f...
Additional file 1. List of investigators in the GEM (Grupo Español de Mieloma)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group. -
Additional file 3: of Use of health outcome and health service utilization in...
Evaluation of health outcomes indicators; his box presents the detailed evaluation made about each indicator of health outcome from the papers retained in this research. (PDF 63... -
MOESM13 of Effect of tetracycline treatment regimens on antibiotic resistance...
Additional file 13: Figure S13. Prevalence of tet(A), tet(B), sulI and sulII of all batches chronologically on farm 1. Top graph is values prior to treatment (T1), middle graph... -
Additional file 1: Table S1. of Treatment decisions, clinical outcomes, and p...
Treatment costs according to type of first-line treatment received by patients with EGFR Mutâ +â NSCLC. (DOCX 15 kb) -
Synthesis and biological properties of new stilbene derivatives of resveratro...
We developed new stilbene derivatives of resveratrol (E)-1-(4‘-hydroxyphenyl)-2-(3,5-dihydroxyphenyl)ethene) selective for AhR and devoid of affinity for ER. Among the 24... -
dedup_wf_001--3d29a8672a7e2fafb43eb71133cd0655
Investigational medicinal product dossier: [18F]FB-IL2. (DOC 938 kb) -
r37980778c78--af4d5f70aed7b4dd4c9253608989c1c8
We have structurally and magnetically characterized a total of 12 complexes based on the Single-Molecule Magnet (SMM) [MnIII6O2(sao)6(O2CH)2(MeOH) 4] (1) (where sao2- is the... -
dedup_wf_001--28814395f61bfc9c3dec0cb6f05d9c97
Figure S2. Comorbidity prevalence in main analysis compared with sensitivity analyses. (DOC 104 kb) -
r37980778c78--98ad233a19199dd6829c44ca4f4531f4
A functional cell-based screen identified 3-(4-chlorophenyl)-3-(2-(dimethylamino)ethyl)isochroman-1-one hydrochloride (AC-7954, 1) as a nonpeptidic agonist of the urotensin-II... -
Additional file 1 of Human bone marrow mesenchymal stem cell-derived exosomes...
Additional file 1: Table S1. Primers used for qRT-PCR. -
Olefin Metathesis in Cyclic Ether Formation. Direct Conversion of Olefinic Es...
Department of Chemistry, The Scripps Research Institute 10666 North Torrey Pines Road, La Jolla, California 92037 Department of Chemistry and Biochemistry UniVersity of... -
dedup_wf_001--60939b4684b669476c560014a85d44b8
Figure S1. HPV16 E6/E7 specific T cell reactivity testing. Figure S2. Conventional (Tbet–) and Tbet+Foxp3+ Tregs can be found in tumor and stroma of OPSCC samples. Figure S3.... -
Additional file 3: of Oral epigallocatechin-3-gallate for treatment of dystro...
Detailed adverse events for EGCG and placebo treatment. * indicates the adverse events reported as severe by investigators. (DOC 41 kb) -
Additional file 1: of Multiple strategy peer-taught evidence-based medicine c...
The courseâ s curriculum. (DOCX 13Â kb)